WHO monographs on selected medicinal plants - travolekar.ru

WHO monographs on selected medicinal plants - travolekar.ru WHO monographs on selected medicinal plants - travolekar.ru

20.01.2015 Views

ong>WHOong> ong>monographsong> on selected medicinal plants Paediatric use See Contraindications. Other precautions No information was found. Dosage forms Crude drug, extracts, fruit juice and tablets. Posology (Unless otherwise indicated) Adult daily oral dose: 10–15 ml of fresh juice (1); 2–15 g of dried crude drug (25, 28, 30). References 1. The Ayurvedic pharmacopoeia of India, Part I. Vol. II, 1st ed. New Delhi, Ministry of Health & Family Welfare, Department of Indian System of Medicine and Homeopathy, 1999. 2. Perry LM, Metzger J. Medicinal plants of east and southeast Asia: Attributed properties and uses. Cambridge, MA, MIT Press, 1980. 3. de Padua LS, Bunyapraphatsara N, Lemmens RHMJ, eds. Plant resources of South-East Asia, No 12(1): Medicinal and poisonous plants – 1. Leiden, Backhuys Publishers, 1999. 4. Ross IA. Medicinal plants of the world. Totowa, NJ, Humana Press, 1999. 5. Farnsworth NR, ed. NAPRALERT database. Chicago, University of Illinois at Chicago, IL (an online database available directly through the University of Illinois at Chicago or through the Scientific and Technical Network [STN] of Chemical Abstracts Services), 30 June 2005. 6. Nadkarni AK. Dr. K.M. Nadkarni’s Indian materia medica. Bombay, Popular Prakashan, 1976. 7. Medicinal plants in the South Pacific. Manila, World Health Organization Regional Office for the Western Pacific, 1998 (ong>WHOong> Regional Publications, Western Pacific Series, No. 19). 8. Medicinal plants of India. Vol. II. New Delhi, Indian Council of Medical Research, 1987. 9. Germosén-Robineau L. ed. Farmacopea Vegetal Caribeña. 2nd ed. Leon, Nicaragua, Universitaria, UNAN-Leon, 2005. 10. Medicinal plants in Thailand. Vol. I. Bangkok, Department of Pharmaceutical Botany, Faculty of Pharmacy, Mahidol University, 1996. 11. ong>WHOong> guidelines on assessing quality of herbal medicines with reference to contaminants and residues. Geneva, World Health Organization, 2007. 12. European Pharmacopoeia, 5th ed. Strasbourg, Directorate for the Quality of Medicines of the Council of Europe, 2005. 206

Fructus Momordicae 13. Guidelines for predicting dietary intake of pesticide residues, 2nd rev. ed. Geneva, World Health Organization, 1997 (ong>WHOong>/FSF/FOS/97.7). 14. Sucrow W. Constituents of Momordica charantia. I. 5 , 25-stigmastadien-3- ol and its -D-glucoside. Chemische Berichte, 1966, 99:2765–2777. 15. Sucrow W. Constituents of Momordica charantia. II. Two new 7 -sterols from Momordica charantia. Chemische Berichte, 1966, 99:3559–3567. 16. Ng T, Yeung H. Bioactive constituents of Cucurbitaceae plants with special emphasis on Momordica charantia and Tricosanthes kirilowii. Proceedings 5th Symposium Medicinal Plants and Spices. Seoul, Korea, 1984. 17. Yeung HW et al. Trichosanthin, -momocharin and -momocharin: identity of abortifacient and ribosome-inactivating proteins. International Journal of Peptide and Protein Research, 1988, 31:265–268. 18. Tse PMF et al. New ribosome-inactivating proteins from seeds and fruits of the bitter gourd Momordica charantia. International Journal of Biochemistry and Cell Biology, 1999, 31:895–901. 19. Murakami T et al. Medicinal food stuffs. XXI. Structures of new cucurbitanetype triterpene glycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type triterpene saponins, goyasaponins I, II, and III, from the fresh fruit of Japanese Momordica charantia L. Chemistry and Pharmaceutical Bulletin, 2001, 49:54–63. 20. Xiao ZY, Chen D, Si J. [Chemical constituents of Momordica charantia.] Zhongcaoyao, 2000, 31:571–573 [in Chinese]. 21. Okabe H, Miyahara Y, Yamauchi T. Studies on the constituents of Momordica charantia. 3. Characterization of new cucurbitacin glycosides of the immature fruits. (1). Structures of momordicosides G, F 1 , F 2 and I. Chemistry and Pharmaceutical Bulletin, 1982, 30:3977–3986. 22. Okabe H, Miyahara Y, Yamauchi T. Studies on the constituents of Momordica charantia L. IV. Characterization of new cucurbitacin glycosides of the immature fruits. (2). Structures of bitter glycosides, momordicosides K and L. Chemistry and Pharmaceutical Bulletin, 1982, 30:4334–4340. 23. Horax R. et al. Total phenolic contents and phenolic acid constituents in 4 varieties of bitter melons (Momordica charantia) and antioxidant activities of their extracts. Journal of Food Science, 2005, 70:C275–280. 24. Ahmad N et al. Effect of Momordica charantia (Karolla) extracts on fasting and postprandial serum glucose levels in NIDDM patients. Bangladesh Medical Research Council Bulletin, 1999, 25:11–13. 25. Akhtar MS. Trial of Momordica charantia Linn (Karela) powder in patients with maturity-onset diabetes. Journal of the Pakistan Medical Association, 1982, 32:106–107. 26. Baldwa VS et al. Clinical trial in patients with diabetes mellitus of an insulinlike compound obtained from a plant source. Uppsala Journal of Medical Science, 1977, 82:39. 27. Bielenberg J. Bittermelone-Blutzuckersenkung durch ergänzende Bilanziert diät mit Momordica charantia [Bitter melon-reduction of blood sugar levels by supplementary balanced diet with Momordica charantia]. Arztezeitschrift für Naturheilverfahren, 2004, 45:96–101. 207

F<strong>ru</strong>ctus Momordicae<br />

13. Guidelines for predicting dietary intake of pesticide residues, 2nd rev. ed. Geneva,<br />

World Health Organizati<strong>on</strong>, 1997 (<str<strong>on</strong>g>WHO</str<strong>on</strong>g>/FSF/FOS/97.7).<br />

14. Sucrow W. C<strong>on</strong>stituents of Momordica charantia. I. 5 , 25-stigmastadien-3-<br />

ol and its -D-glucoside. Chemische Berichte, 1966, 99:2765–2777.<br />

15. Sucrow W. C<strong>on</strong>stituents of Momordica charantia. II. Two new 7 -sterols<br />

from Momordica charantia. Chemische Berichte, 1966, 99:3559–3567.<br />

16. Ng T, Yeung H. Bioactive c<strong>on</strong>stituents of Cucurbitaceae <strong>plants</strong> with special<br />

emphasis <strong>on</strong> Momordica charantia and Tricosanthes kirilowii. Proceedings<br />

5th Symposium Medicinal Plants and Spices. Seoul, Korea, 1984.<br />

17. Yeung HW et al. Trichosanthin, -momocharin and -momocharin: identity<br />

of abortifacient and ribosome-inactivating proteins. Internati<strong>on</strong>al Journal of<br />

Peptide and Protein Research, 1988, 31:265–268.<br />

18. Tse PMF et al. New ribosome-inactivating proteins from seeds and f<strong>ru</strong>its of<br />

the bitter gourd Momordica charantia. Internati<strong>on</strong>al Journal of Biochemistry<br />

and Cell Biology, 1999, 31:895–901.<br />

19. Murakami T et al. Medicinal food stuffs. XXI. St<strong>ru</strong>ctures of new cucurbitanetype<br />

triterpene glycosides-a, -b, -c, -d, -e, -f, -g, and -h, and new oleanane-type<br />

triterpene sap<strong>on</strong>ins, goyasap<strong>on</strong>ins I, II, and III, from the fresh f<strong>ru</strong>it of Japanese<br />

Momordica charantia L. Chemistry and Pharmaceutical Bulletin, 2001, 49:54–63.<br />

20. Xiao ZY, Chen D, Si J. [Chemical c<strong>on</strong>stituents of Momordica charantia.]<br />

Zh<strong>on</strong>gcaoyao, 2000, 31:571–573 [in Chinese].<br />

21. Okabe H, Miyahara Y, Yamauchi T. Studies <strong>on</strong> the c<strong>on</strong>stituents of Momordica<br />

charantia. 3. Characterizati<strong>on</strong> of new cucurbitacin glycosides of the immature<br />

f<strong>ru</strong>its. (1). St<strong>ru</strong>ctures of momordicosides G, F 1<br />

, F 2<br />

and I. Chemistry<br />

and Pharmaceutical Bulletin, 1982, 30:3977–3986.<br />

22. Okabe H, Miyahara Y, Yamauchi T. Studies <strong>on</strong> the c<strong>on</strong>stituents of Momordica<br />

charantia L. IV. Characterizati<strong>on</strong> of new cucurbitacin glycosides of the<br />

immature f<strong>ru</strong>its. (2). St<strong>ru</strong>ctures of bitter glycosides, momordicosides K and<br />

L. Chemistry and Pharmaceutical Bulletin, 1982, 30:4334–4340.<br />

23. Horax R. et al. Total phenolic c<strong>on</strong>tents and phenolic acid c<strong>on</strong>stituents in<br />

4 varieties of bitter mel<strong>on</strong>s (Momordica charantia) and antioxidant activities<br />

of their extracts. Journal of Food Science, 2005, 70:C275–280.<br />

24. Ahmad N et al. Effect of Momordica charantia (Karolla) extracts <strong>on</strong> fasting<br />

and postprandial se<strong>ru</strong>m glucose levels in NIDDM patients. Bangladesh<br />

Medical Research Council Bulletin, 1999, 25:11–13.<br />

25. Akhtar MS. Trial of Momordica charantia Linn (Karela) powder in patients<br />

with maturity-<strong>on</strong>set diabetes. Journal of the Pakistan Medical Associati<strong>on</strong>,<br />

1982, 32:106–107.<br />

26. Baldwa VS et al. Clinical trial in patients with diabetes mellitus of an insulinlike<br />

compound obtained from a plant source. Uppsala Journal of Medical<br />

Science, 1977, 82:39.<br />

27. Bielenberg J. Bittermel<strong>on</strong>e-Blutzuckersenkung durch ergänzende Bilanziert<br />

diät mit Momordica charantia [Bitter mel<strong>on</strong>-reducti<strong>on</strong> of blood sugar levels<br />

by supplementary balanced diet with Momordica charantia]. Arztezeitschrift<br />

für Naturheilverfahren, 2004, 45:96–101.<br />

207

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!